Detalhe da pesquisa
1.
Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.
J Infect Dis
; 217(4): 567-571, 2018 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325161
2.
Persistence of Wild-Type Japanese Encephalitis Virus Strains Cross-Neutralization 5 Years After JE-CV Immunization.
J Infect Dis
; 215(2): 221-227, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27815383
3.
A fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Turkish infants and toddlers
Turk J Med Sci
; 47(4): 1247-1256, 2017 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29156870
4.
Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India.
BMC Infect Dis
; 14: 156, 2014 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24656175
5.
Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine: randomized double-blind phase II evaluation of safety and immunogenicity.
Hum Vaccin
; 6(11): 906-14, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20864814
6.
Safety biomarkers for development of vaccines and biologics: Report from the safety biomarkers symposium held on November 28-29, 2017, Marcy l'Etoile, France.
Vaccine
; 38(51): 8055-8063, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33187767
7.
Pre-exposure purified vero cell rabies vaccine and concomitant routine childhood vaccinations: 5-year post-vaccination follow-up study of an infant cohort in Vietnam.
J Trop Pediatr
; 55(1): 26-31, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18048461
8.
Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine.
Hum Vaccin Immunother
; 15(1): 72-79, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30230947
9.
Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration.
Hum Vaccin Immunother
; 15(3): 658-668, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30513252
10.
Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers.
Pediatr Infect Dis J
; 38(3): 317-322, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30408001
11.
Long-term anti-rabies antibody persistence following intramuscular or low-dose intradermal vaccination of young Vietnamese children.
Trans R Soc Trop Med Hyg
; 102(3): 294-6, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18191971
12.
Immunogenicity and Safety of Primary and Booster Vaccinations of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine in Healthy Infants and Toddlers in Germany and the Czech Republic.
Pediatr Infect Dis J
; 37(8): 823-830, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29762363
13.
A Randomized, Controlled Study of DTaP-IPV-HB-PRP-T, a Fully Liquid Hexavalent Vaccine, Administered in a 3-, 5- and 11- to 12-month Schedule.
Pediatr Infect Dis J
; 36(1): 87-93, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27753797
14.
Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.
Pediatr Infect Dis J
; 36(4): e108-e113, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28030526
15.
A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America.
Pediatr Infect Dis J
; 36(11): e272-e282, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28719500
16.
Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
Vaccine
; 34(46): 5664-5669, 2016 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27686833
17.
Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety.
Pediatr Infect Dis J
; 33(6): 643-9, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24717964
18.
Concomitant administration of live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV) and measles, mumps, rubella (MMR) vaccine: randomized study in toddlers in Taiwan.
Vaccine
; 32(41): 5363-9, 2014 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24631095
19.
Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children.
Hum Vaccin Immunother
; 9(4): 889-97, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23442823
20.
Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial.
Hum Vaccin Immunother
; 8(7): 929-37, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22777096